Partners Capital Investment Group, LLP Bei Gene, Ltd. Transaction History

Partners Capital Investment Group, LLP

  • $5.57 Billion
  • Q1 2025

A detailed history of Partners Capital Investment Group, LLP transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Partners Capital Investment Group, LLP holds 23,936 shares of BGNE stock, worth $5.43 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
23,936
Holding current value
$5.43 Million
% of portfolio
0.1%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
BUY
$175.1 - $226.71 $4.19 Million - $5.43 Million
23,936 New
23,936 $5.43 Million
Q3 2024

Nov 05, 2024
SELL
$143.93 - $224.51 $192,578 - $300,394
-1,338 Reduced 10.81%
11,041 $2.48 Million
Q2 2024

Aug 13, 2024
BUY
$129.52 - $174.32 $1.6 Million - $2.16 Million
12,379 New
12,379 $1.77 Million
Q4 2023

Feb 12, 2024
BUY
$158.67 - $201.58 $2.43 Million - $3.09 Million
15,316 New
15,316 $2.76 Million
Q3 2022

Nov 14, 2022
SELL
$131.8 - $202.24 $2.41 Million - $3.7 Million
-18,311 Closed
0 $0
Q2 2022

Aug 15, 2022
SELL
$121.11 - $216.05 $16.4 Million - $29.2 Million
-135,081 Reduced 88.06%
18,311 $2.96 Million
Q1 2022

May 16, 2022
BUY
$146.52 - $269.56 $5.39 Million - $9.92 Million
36,794 Added 31.56%
153,392 $28.9 Million
Q4 2021

Feb 14, 2022
BUY
$248.56 - $389.34 $1.11 Million - $1.73 Million
4,452 Added 3.97%
116,598 $31.6 Million
Q3 2021

Nov 15, 2021
SELL
$249.6 - $403.14 $199,680 - $322,512
-800 Reduced 0.71%
112,146 $40.7 Million
Q2 2021

Aug 16, 2021
BUY
$292.75 - $367.01 $1.72 Million - $2.16 Million
5,889 Added 5.5%
112,946 $38.8 Million
Q1 2021

May 17, 2021
BUY
$260.64 - $382.12 $21.2 Million - $31 Million
81,162 Added 313.43%
107,057 $37.3 Million
Q4 2020

Feb 16, 2021
BUY
$221.31 - $316.61 $714,609 - $1.02 Million
3,229 Added 14.25%
25,895 $6.69 Million
Q3 2020

Nov 13, 2020
SELL
$189.18 - $286.44 $479,571 - $726,125
-2,535 Reduced 10.06%
22,666 $6.49 Million
Q2 2020

Aug 12, 2020
SELL
$123.9 - $195.41 $495,600 - $781,640
-4,000 Reduced 13.7%
25,201 $4.75 Million
Q4 2019

Feb 13, 2020
BUY
$115.78 - $208.34 $3.38 Million - $6.08 Million
29,201 New
29,201 $4.84 Million

Others Institutions Holding BGNE

# of Institutions
295
Shares Held
40.1M
Call Options Held
111K
Put Options Held
114K
View Full List

About BeiGene, Ltd.

BGNE Quotes by TradingView
  • Ticker BGNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,700,000
  • Market Cap $23.5B
  • Description
  • BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...
More about BGNE
Track This Portfolio

Track Partners Capital Investment Group, LLP Portfolio

Follow Partners Capital Investment Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Partners Capital Investment Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Partners Capital Investment Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email